Matt Hancock
@MattHancock
Help is on its way. The MHRA has formally authorised the Pfizer/BioNTech vaccine for Covid-19. The NHS stands ready to start vaccinating early next week. The UK is the first country in the world to have a clinically approved vaccine for supply.
Pfizer say the jab is 95% effective and has passed its safety checks. It has to be stored a very low temperatures, which Mr Hancock described as a ‘challenge’ but one the NHS was prepared for. He told Sky News ‘This is a challenging rollout and the NHS in all parts of the UK stands ready to make that happen. ‘They are used to handling vaccines and medicines like this, with these sorts of conditions. ‘It’s not easy but we’ve got those plans in place, so this morning I spoke to my counterparts in the devolved nations to make sure that we are all ready to roll out this vaccine … from early next week.’ Chairman and chief executive officer Dr Albert Bourla said previously: ‘We have known since the beginning of this journey that patients are waiting, and we stand ready to ship Covid-19 vaccine doses as soon as potential authorisations will allow us.’ The vaccine is one of a number of jabs that had been racing for official approval.
A volunteer is injected with the Pfizer/BioNtech jab during testing (Picture: EPA)
The UK government have agreed a deal to get 100 million doses of the Oxford and Astrazeneca jab, which is said to be up to 90% effective – though questions have been raised about that figure. It also plans to bring in seven million doses of the Moderna vaccine, which – like the Pfizer jab but unlike Oxford’s version – needs to be stored at very low temperatures. Moderna says its product is ’95% effective’ Russia also claims its Sputnik vaccine has the same level of effectiveness, but the UK is likely to reject that jab, according to The Daily Telegraph. Each vaccine will become available to the public at different times based on authorisation and when the UK receives its doses.
Source:metro.co.uk/